Nectar Lifesciences Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
676.15 Cr.
|
P/BV
|
0.64
|
Book Value (Rs.)
|
47.47
|
52 Week High/Low (Rs.)
|
46/15
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
21/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Gross] | 1746.56 | 1925.52 | 1763.74 | 2642.86 | 3112.86 |
Less: Excise/Sevice Tax/Other Levies | 222.89 | 256.69 | 220.45 | 276.48 | 329.99 |
Revenue From Operations [Net] | 1523.67 | 1668.83 | 1543.30 | 2366.38 | 2782.87 |
Total Operating Revenues | 1523.67 | 1668.83 | 1543.30 | 2366.38 | 2782.87 |
| | | | | |
Other Income | 43.18 | 11.32 | 3.79 | 4.36 | 6.04 |
Total Revenue | 1566.85 | 1680.15 | 1547.09 | 2370.74 | 2788.91 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1200.84 | 1206.88 | 1028.40 | 1834.03 | 2225.32 |
Purchase Of Stock-In Trade | 0.00 | 0.44 | 24.42 | 28.80 | 42.82 |
Operating And Direct Expenses | 172.14 | 146.37 | 128.62 | 138.95 | 153.11 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -41.55 | 15.81 | 104.29 | -4.22 | -50.43 |
Employee Benefit Expenses | 77.78 | 74.55 | 73.37 | 81.00 | 79.90 |
Finance Costs | 79.49 | 78.81 | 112.04 | 125.83 | 148.14 |
Depreciation And Amortisation Expenses | 59.12 | 56.97 | 60.25 | 60.77 | 63.26 |
Other Expenses | 61.46 | 66.24 | 75.16 | 68.12 | 67.98 |
Total Expenses | 1609.27 | 1646.07 | 1606.54 | 2333.27 | 2730.09 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -42.42 | 34.08 | -59.45 | 37.47 | 58.82 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | -25.32 | 0.00 | 0.00 |
Profit/Loss Before Tax | -42.42 | 34.08 | -84.77 | 37.47 | 58.82 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | -18.24 | 9.03 | -11.50 | 5.68 | 11.22 |
Total Tax Expenses | -18.24 | 9.03 | -11.50 | 5.68 | 11.22 |
Profit/Loss After Tax And Before ExtraOrdinary Items | -24.18 | 25.05 | -73.26 | 31.79 | 47.60 |
| | | | | |
Profit/Loss From Continuing Operations | -24.18 | 25.05 | -73.26 | 31.79 | 47.60 |
| | | | | |
Profit/Loss For The Period | -24.18 | 25.05 | -73.26 | 31.79 | 47.60 |
Consolidated Profit/Loss After MI And Associates | -24.18 | 25.05 | -73.26 | 31.79 | 47.60 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 |
Diluted EPS (Rs.) | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 0.00 | 1.12 | 1.12 | 1.35 |
Tax On Dividend | 0.00 | 0.00 | 0.11 | 0.23 | 0.00 |